TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
148.00
+1.00 (0.68%)
At close: Mar 3, 2026, 4:00 PM EST
146.70
-1.30 (-0.88%)
After-hours: Mar 3, 2026, 7:49 PM EST
TransMedics Group Employees
TransMedics Group had 728 employees as of December 31, 2024. The number of employees increased by 144 or 24.66% compared to the previous year.
Employees
728
Change (1Y)
144
Growth (1Y)
24.66%
Revenue / Employee
$831,723
Profits / Employee
$261,389
Market Cap
5.08B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 728 | 144 | 24.66% |
| Dec 31, 2023 | 584 | 372 | 175.47% |
| Dec 31, 2022 | 212 | 64 | 43.24% |
| Dec 31, 2021 | 148 | 38 | 34.55% |
| Dec 31, 2020 | 110 | 1 | 0.92% |
| Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 29, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bruker | 11,396 |
| Integer Holdings | 11,000 |
| Bio-Rad Laboratories | 7,450 |
| Bio-Rad Laboratories | 7,450 |
| Globus Medical | 6,000 |
| Haemonetics | 3,023 |
| LivaNova | 2,900 |
| iRhythm Holdings | 2,400 |
TMDX News
- 4 days ago - TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results - PRNewsWire
- 6 days ago - TransMedics Group, Inc. (TMDX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 11 days ago - TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 14 days ago - TransMedics to Present at Upcoming March Investor Conferences - PRNewsWire
- 21 days ago - TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - PRNewsWire
- 22 days ago - TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial - PRNewsWire
- 4 weeks ago - TransMedics: Italian NOP Program Reinforces Huge International Opportunity - Seeking Alpha